Absci Corp
ABSI
Company Profile
Business description
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
Contact
18105 SE Mill Plain Boulevard
VancouverWA98683
USAT: +1 360 949-1041
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
157
Stocks News & Analysis
stocks
Paying more for new customers is a troubling sign for ASX share
Shares fall close to 18% after reporting higher marketing expenses.
stocks
10 US stocks with the largest fair value estimate increases during Q4 earnings
Semiconductor companies Sandisk, Teradyne, and Applied Materials saw the largest fair value hikes.
stocks
Berkshire Hathaway earnings: Cash hits record $373 billion on mostly solid results across the firm
We think Berkshire Hathaway stock is fairly valued.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,117.10 | 303.40 | -3.22% |
| CAC 40 | 8,204.45 | 100.61 | 1.24% |
| DAX 40 | 24,205.36 | 414.71 | 1.74% |
| Dow JONES (US) | 48,739.41 | 238.14 | 0.49% |
| FTSE 100 | 10,580.13 | 199.98 | -1.86% |
| HKSE | 25,249.48 | 1,131.54 | -4.29% |
| NASDAQ | 22,807.48 | 290.79 | 1.29% |
| Nikkei 225 | 54,245.54 | 4,507.85 | -7.67% |
| NZX 50 Index | 13,551.38 | 119.33 | -0.87% |
| S&P 500 | 6,869.50 | 52.87 | 0.78% |
| S&P/ASX 200 | 8,901.20 | 280.50 | -3.05% |
| SSE Composite Index | 4,082.47 | 40.20 | -0.98% |